Resumo

GARCIA-CHAVEZ, Jaime et al. Mexican consensus on the diagnosis and treatment of Glanzmann thrombasthenia. Gac. Méd. Méx [online]. 2022, vol.158, n.spe4, pp.1-17.  Epub 20-Jan-2023. ISSN 2696-1288.  https://doi.org/10.24875/gmm.m22000691.

Platelets have a central role in several physiological scenarios including hemostasis. Platelets bind each other during platelet aggregation allowing the proper formation of the clot; to be appropriate, platelet aggregation requires the glycoproteic complex IIb/IIIa (GPIIb/IIIa). Every platelet function abnormality both, congenital or acquired, impedes clot formation and favors bleeding episodes. Hereditary platelet abnormalities are rare and, until recently, they were almost ignored. Among these disorders, Glanzmann Thrombasthenia (GT) is a widely recognized abnormality in which platelet counts may be normal, but their function is affected. GT is an autosomal, recessive disease that causes life-long bleeding of different intensity. Main biochemical abnormality resides in GPIIb/IIIa. Bleeding is typically mucocutaneous: easy bruising, purpura, and nose and gum bleeds; less frequently are gastrointestinal bleeds, hemarthrosis, or intracranial. Menorrhagia and hyperpolymenorrhea are common findings in in women and may be the cause of anemia requiring blood transfusions at fertile age. GT affects all ethnic groups and its prevalence ranges between 1/40,000 to 1/400,000. Despite this worldwide information regarding GT, only a few guidelines and recommendations have been published, most of them based on expert opinions. In Mexico, GT is rare and there is not a general recommendation regarding its diagnosis and treatment. The aim of this document was to establish a consensus to suggest a general guideline for the diagnosis and treatment of GT in Mexico.

Palavras-chave : Glanzmann thrombasthenia; Platelets; Bleeding; Functional platelet abnormalities; Hereditary bleeding disorders.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )